Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03834714 · ClinicalTrials.gov registry record · NA
Noise Exposure and Near-Infrared Light
A NA study of Hearing Loss, Noise-Induced, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 3
- Study locations
NCT03834714: Completed NA study of Hearing Loss, Noise-Induced, sponsored by University of Miami.
NCT03834714 is a NA study of Hearing Loss, Noise-Induced that has completed, run by University of Miami. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03834714, a NA study of Hearing Loss, Noise-Induced, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 3
- Study locations
Study Summary
The primary objective of this work is to determine the effect noise has on the auditory system (both auditory health and performance) and also the degree to which the effect of pre-noise therapy such as Near Infrared (NIR) light can mitigate the effects of noise exposure.
Primary Outcome
Auditory function tests will be measured through the change in air conduction threshold measurements from 500 up to 8000 Hz
Conditions Studied
Interventions
- DEVICE Near Infrared Light
- OTHER Noise Stimulus
- DEVICE Sham Near Infrared Light
Study Locations (3)
Alabama
- U.S. Army Aeromedical Research Laboratory - Fort Rucker
Florida
- University of Miami Miller School of Medicine - Miami
Ohio
- Wright-Patterson Air Force Base - Wright-Patterson Air Force Base
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2020-02-18 |
| Est. Completion | 2021-12-23 |
| Phase | NA |
What the finished NCT03834714 record still lists
NCT03834714 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Hearing Loss, Noise-Induced appearing as the primary indexed condition, and to 3 interventions - of which Near Infrared Light is the first listed.
NCT03834714 reports a single indexed study location in Alabama, Florida, Ohio.
Frequently Asked Questions
What is clinical trial NCT03834714 about?
NCT03834714 is a clinical study titled "Noise Exposure and Near-Infrared Light". The primary objective of this work is to determine the effect noise has on the auditory system (both auditory health and performance) and also the degree to which the effect of pre-noise therapy such as Near Infrared (NIR) light can mitigate the effects of noise exposure.
What is the current status of trial NCT03834714?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2020-02-18. Estimated completion is 2021-12-23.
What conditions does trial NCT03834714 study?
This clinical trial studies the following conditions: Hearing Loss, Noise-Induced.
What interventions are being tested in trial NCT03834714?
The interventions under investigation include: Near Infrared Light (DEVICE), Noise Stimulus (OTHER), Sham Near Infrared Light (DEVICE).
Who is sponsoring clinical trial NCT03834714?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03834714 being conducted?
This trial has 3 study locations across Alabama, Florida, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss, Noise-Induced
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03834714's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy